| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |